HIT Consultant August 23, 2024
Syed Hamza Sohail

What You Should Know:

Falfurrias Management Partners (Falfurrias), a Charlotte-based private equity firm focused on growth-oriented, middle-market businesses, today announced its investment in Jumo Health, an innovative and award-winning clinical trial solutions company driving better outcomes for clinical trials globally.

Jumo Health develops creative, patient-centric educational solutions that improve health literacy to accelerate clinical trial enrollment and increase participant retention.

Falfurrias Capital Partners Invests in Jumo Health to Enhance Clinical Trial Engagement and Diversity

Falfurrias Capital Partners has announced an investment in Jumo Health, aiming to address critical challenges in clinical trials, such as low enrollment, high dropout rates, and the lack of diverse representation. This strategic investment will bring new resources and expertise to Jumo Health, enhancing...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Clinical Trials, Investments, Trends
The future of clinical trials: Are we ready?
Amgen starts two critical late-stage trials for weight loss drug MariTide
Anti-CRO Lindus Health Raises $55M in Series B Funding to Transform the Clinical Trial Landscape
EU launches clinical trial map for patients and professionals
Expanding Clinical Trial Access Amid DEI Challenges

Share This Article